Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)

Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)

The uremic syndrome, which is the clinical expression of chronic kidney disease (CKD), is a complex amalgam of accelerated aging and organ dysfunctions, whereby cardio-vascular disease plays a capital role. In this narrative review, we offer a summary of the current conservative (medical) treatment...

Full description

Bibliographic Details
Main Authors:	Raymond Vanholder, Steven Van Laecke, Griet Glorieux, Francis Verbeke, Esmeralda Castillo-Rodriguez, Alberto Ortiz
Format:	Article
Language:	English
Published:	MDPI AG 2018-06-01
Series:	Toxins
Subjects:	chronic kidney disease CKD mortality outcomes uremia medication lifestyle diet prevention cardiovascular disease
Online Access:	http://www.mdpi.com/2072-6651/10/6/237

Similar Items

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
by: Raymond Vanholder, et al.
Published: (2018-01-01)

Intestinal Barrier Function in Chronic Kidney Disease
by: Björn Meijers, et al.
Published: (2018-07-01)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
by: Raymond Vanholder, et al.
Published: (2022-03-01)

Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients
by: Fellype Carvalho Barreto, et al.
Published: (2014-09-01)

Tissue-Specific <sup>1</sup>H-NMR Metabolomic Profiling in Mice with Adenine-Induced Chronic Kidney Disease
by: Ram B. Khattri, et al.
Published: (2021-01-01)

Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease
by: Maribel Diaz-Ricart, et al.
Published: (2020-06-01)

Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
by: Anastasia V. Poznyak, et al.
Published: (2022-08-01)

The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
by: Zarina Ebrahim, et al.
Published: (2022-02-01)

Animal models of pediatric chronic kidney disease. Is adenine intake an appropriate model?
by: Débora Claramunt, et al.
Published: (2015-11-01)

Animal models of pediatric chronic kidney disease. Is adenine intake an appropriate model?
by: Débora Claramunt, et al.
Published: (2015-11-01)

Vascular Calcification: An Important Understanding in Nephrology
by: Zununi Vahed S, et al.
Published: (2020-05-01)

Innovative Three-Dimensional Microscopic Analysis of Uremic Growth Plate Discloses Alterations in the Process of Chondrocyte Hypertrophy: Effects of Growth Hormone Treatment
by: Ángela Fernández-Iglesias, et al.
Published: (2020-06-01)

Obstacles to Early Diagnosis and Treatment of Pruritus in Patients with Chronic Kidney Disease: Current Perspectives
by: Jha CM, et al.
Published: (2022-12-01)

Role of indoxyl sulfate in the progression of chronic kidney disease and associated cardiovascular diseases
by: Yan-yan He, et al.
Published: (2024-02-01)

Endodontic management of patient with established chronic kidney disease undergoing hemodialysis
by: Navin Mishra, et al.
Published: (2012-01-01)

Immune dysfunction in chronic kidney disease
by: Sara Cardoso Fernandes, et al.
Published: (2021-12-01)

Effect of simplified dietary advice on nutritional status and uremic toxins in chronic kidney disease participants
by: Zarina Ebrahim, et al.
Published: (2022-11-01)

Beta Blockade Prevents Cardiac Morphological and Molecular Remodelling in Experimental Uremia
by: Shanmugakumar Chinnappa, et al.
Published: (2023-12-01)

Orofacial dyskinesia in uremia in polycystic kidney disease
by: Nidhi Arora, et al.
Published: (2023-01-01)

Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
by: Francis Verbeke, et al.
Published: (2022-07-01)

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study
by: Mikhail M. Batyushin
Published: (2021-06-01)

The KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD): A Korean Chronic Kidney Disease Cohort
by: Kook-Hwan Oh, et al.
Published: (2022-07-01)

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
by: Natsumi Uchiyama-Matsuoka, et al.
Published: (2022-11-01)

Dynamics of Electroencephalogram (EEG) in Different Stages of Chronic Kidney Disease
by: Pradyumna Gadewar, et al.
Published: (2015-03-01)

Impact of Kidney Failure Risk Prediction Clinical Decision Support on Monitoring and Referral in Primary Care Management of CKD: A Randomized Pragmatic Clinical TrialPlain-Language Summary
by: Lipika Samal, et al.
Published: (2022-07-01)

CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management
by: Hector Alvarado Verduzco, et al.
Published: (2020-09-01)

Bone Disease in Chronic Kidney Disease and Kidney Transplant
by: Ezequiel Bellorin-Font, et al.
Published: (2022-12-01)

CKD and Rapid Kidney Function Decline During the COVID-19 Pandemic
by: Clarissa J. Diamantidis, et al.
Published: (2023-09-01)

Psychological Distress and Self-Management in CKD: A Cross-Sectional Study
by: Cinderella K. Cardol, et al.
Published: (2023-10-01)

Leptospirosis kidney disease: Evolution from acute to chronic kidney disease
by: Li-Fang Chou, et al.
Published: (2023-08-01)

European Kidney Function Consortium Equation vs. Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Refit Equations for Estimating Glomerular Filtration Rate: Comparison with CKD-EPI Equations in the Korean Population
by: Hanah Kim, et al.
Published: (2022-07-01)

The association between changes in lifestyle behaviors and the incidence of chronic kidney disease (CKD) in middle-aged and older men
by: Ryoma Michishita
Published: (2017-08-01)

Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD
by: Kevin Li, et al.
Published: (2021-02-01)

Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease
by: Rupinder Kaur, et al.
Published: (2023-10-01)

SCREENING OF GERIATRIC DOGS FOR CHRONIC KIDNEY DISEASE AND ITS MANAGE
by: R.S. Ghag, et al.
Published: (2017-01-01)

Chinese Clinical Practice Guideline for the Management of “CKD-PeriDialysis”-the Periods Prior to and in the Early-Stage of Initial Dialysis
Published: (2022-12-01)

Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective
by: Sonnal Lohia, et al.
Published: (2022-02-01)

Altered Emotional Phenotypes in Chronic Kidney Disease Following 5/6 Nephrectomy
by: Yeon Hee Yu, et al.
Published: (2021-06-01)

Ulcer in a dialysis patient: Calciphylaxis or something simpler
by: Amr Mohamed, et al.
Published: (2022-09-01)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
by: Mieke Steenbeke, et al.
Published: (2022-03-01)